$AXON

Kalinowski Caitlin Elizabeth sold $38K of AXON

Kalinowski Caitlin Elizabeth sold 80 shares of AXON ENTERPRISE, INC. (AXON) at $475.18 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AXON
Neutral
low confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure updates the insider-activity record but does not indicate a new corporate development.

02

Market read

Traders may note insider selling for sentiment, but there is no fundamental trigger to drive a sustained repricing.

03

What to watch

No context on total insider holdings, prior sales cadence, or whether other directors/officers are buying; without that, directional inference is weak.

Relevance 6/10Novelty 7/10Timing: after the 2026-06-01 sale, filed 2026-06-02

Background

The filing is an SEC Form 4 insider transaction: a director reported an open-market sale of Axon shares.

Company-level read

Ticker impact

$AXONNeutralLow confidence
Context

Axon Enterprise director Caitlin Elizabeth Kalinowski sold 80 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Low near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

This is a routine Form 4 datapoint with a small share count relative to typical trading volumes and no accompanying corporate event (earnings, guidance, deal, or litigation).

Market effects

Minimal; single-insider sale does not reset sector expectations for public-safety/technology peers.

None.

None.

Counterpoint

Because the sale is small and not tied to a 10b5-1 plan, it could reflect diversification or personal liquidity rather than bearish expectations.

Key entities

  • AXON ENTERPRISE, INC.

    Public company whose director reported an open-market sale of shares on SEC Form 4.

  • Kalinowski Caitlin Elizabeth

    Axon director who sold 80 shares at $475.1850 on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.